Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Engel

Showing results (631-640 of 873) with videos related to

Pageof 88
Sort By:
Current Medical Research and Opinion|May 27, 2017
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapyYehuda Handelsman, Brett Lauring, Ira Gantz, et al.
Diabetes, Obesity & Metabolism|November 9, 2011
Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetesJ Wainstein, L Katz, S S Engel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized StudySam Miller, Tania Krumins, Haojin Zhou, et al.
Proceedings. Biological Sciences|April 10, 2019
Basal polyphagan beetles in mid-Cretaceous amber from Myanmar: biogeographic implications and long-term morphological stasisChenyang Cai, John F Lawrence, Shûhei Yamamoto, et al.
Current Biology : CB|January 6, 2026
Potter wasp nests in Cretaceous amberYao Yao, James M Carpenter, Zhu Bing-Yue, et al.
Diabetes Research and Clinical Practice|April 12, 2011
Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizideThomas L Seck, Samuel S Engel, Debora E Williams-Herman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized StudyGeorge Grunberger, Sarah Camp, Jeremy Johnson, et al.
Infection and Immunity|May 1, 1997
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infectionR J O'Callaghan, M C Callegan, J M Moreau, et al.
Arthropod Structure & Development|June 1, 2025
Unraveling the insect head: Segmentation and pancrustacean homologiesPatricia Nel, Michael S Engel, Carmen Soriano, et al.
Nature Communications|March 28, 2026
Iminium-linked hyperporphyrin covalent organic framework mediates type I photodynamic therapy via a photoredox processZhibei Zhou, Yuxuan Xiong, Zitong Wang, et al.
Pageof 88

Showing results (631-640 of 873) with videos related to

Sort By:
Pageof 88
Current Medical Research and Opinion|May 27, 2017
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapyYehuda Handelsman, Brett Lauring, Ira Gantz, et al.
Diabetes, Obesity & Metabolism|November 9, 2011
Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetesJ Wainstein, L Katz, S S Engel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized StudySam Miller, Tania Krumins, Haojin Zhou, et al.
Proceedings. Biological Sciences|April 10, 2019
Basal polyphagan beetles in mid-Cretaceous amber from Myanmar: biogeographic implications and long-term morphological stasisChenyang Cai, John F Lawrence, Shûhei Yamamoto, et al.
Current Biology : CB|January 6, 2026
Potter wasp nests in Cretaceous amberYao Yao, James M Carpenter, Zhu Bing-Yue, et al.
Diabetes Research and Clinical Practice|April 12, 2011
Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizideThomas L Seck, Samuel S Engel, Debora E Williams-Herman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized StudyGeorge Grunberger, Sarah Camp, Jeremy Johnson, et al.
Infection and Immunity|May 1, 1997
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infectionR J O'Callaghan, M C Callegan, J M Moreau, et al.
Arthropod Structure & Development|June 1, 2025
Unraveling the insect head: Segmentation and pancrustacean homologiesPatricia Nel, Michael S Engel, Carmen Soriano, et al.
Nature Communications|March 28, 2026
Iminium-linked hyperporphyrin covalent organic framework mediates type I photodynamic therapy via a photoredox processZhibei Zhou, Yuxuan Xiong, Zitong Wang, et al.
Pageof 88